Article

Enhancing Patient Lymphocyte Response to Peritoneal Malignancies Using a Personalized Immunocompetent Microfluidic Co-Culture Platform

2026-02-20

Abstract excerpt

Harnessing patient immune cells via adoptive cellular therapy is a promising cancer therapeutic strategy. However, major challenges remain for advanced solid malignancies, including difficulty isolating sufficient tumor infiltrating lymphocytes (TILs) and limited targeting of diverse neoantigens in heterogenous tumors. To address this, we have developed a tumor-on-a-chip platform with co-cultured patient-derived t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: da746b3f-1724-55bf-93d7-756abe1f471e
DOI: 10.64898/2026.02.19.706377

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Enhancing Patient Lymphocyte Response to Peritoneal Malignancies Using a Personalized Immunocompetent Microfluidic Co-Culture PlatformDOI 10.64898/2026.02.19.706377Read

Microfluidic technologies for immunotherapy studies on solid tumoursSemantic proximity Read

Clonal expansion of personalized anti-tumor T cells from circulation using tumor organoid-immune co-culturesSemantic proximity Read

Novel strategies to improve efficacy of treatment with tumor-infiltrating lymphocytes (TILs) for patients with solid cancers.Semantic proximity Read

Evaluation of natural killer cell tumor homing and effector function in response to CDK4/6 and AURKA inhibition in a melanoma tumor-on-a-chip platformSemantic proximity Read

<i>Ex vivo</i> quantification of anti-tumor T-cell activity upon anti-PD-1 treatment in patient-derived lung tumor-on-chipSemantic proximity Read

Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-culturesSemantic proximity Read

Genetic and phenotypic profiling of single living circulating tumor cells from patients with microfluidics.Semantic proximity Read

Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes.Semantic proximity Read

Ovarian cancer-on-chip for patient-specific profiling of treatment responses to sequential chemotherapy and PD-L1 blockadeSemantic proximity Read

Patient-derived esophageal adenocarcinoma organ chip: a physiologically relevant platform for functional precision oncologySemantic proximity Read

Autologous tumor-immune effusion co-cultures enable ex vivo functional profiling of radiotherapy-immunotherapy combinationsSemantic proximity Read

From spheroids to organoids: next-generation models for CAR-T cell therapy research in solid tumorsSemantic proximity Read